Nasdaq’s opening bell rings for USC-licensed biotech startup
The first USC-licensed startup — a biotech company that has developed an intranasal drug delivery system for brain tumors — is now listed on Nasdaq. To celebrate the direct listing, the USC Stevens Center for Innovation and … Read More »